- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE Capital invests in R2 Technology
R2 Technology strengthened its relationship with GE last month with the signing of an $11 million financing agreement led by GE's financing arm, GE Capital. The financing will be used for working capital purposes as R2 prepares for an initial public
R2 Technology strengthened its relationship with GE last month with the signing of an $11 million financing agreement led by GE's financing arm, GE Capital. The financing will be used for working capital purposes as R2 prepares for an initial public offering that the company plans to launch some time this year. R2 did not disclose what percentage of the Los Altos, CA, company GE Capital now owns.
R2 has developed ImageChecker M1000, a computer-aided diagnosis product for flagging suspicious areas on mammograms. The product is awaiting Food and Drug Administration approval. R2 signed an agreement with GE Medical Systems in April that gives the Milwaukee company rights to the product when sold with full-field digital mammography systems (SCAN 4/29/98). The financing deal with GE Capital was not directly related to the GEMS agreement, according to an R2 spokesperson.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
